| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/07/2004 | EP1434885A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 07/07/2004 | EP1434882A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 07/07/2004 | EP1434879A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 07/07/2004 | EP1434877A2 Chromogenic in situ hybridization methods, kits, and compositions |
| 07/07/2004 | EP1434863A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434859A2 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 07/07/2004 | EP1434798A2 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434794A2 Fragments of heat shock proteins and their use |
| 07/07/2004 | EP1434791A2 Specific binding agents of human angiopoietin-2 |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434787A2 Lp mammalian proteins; related reagents |
| 07/07/2004 | EP1434786A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434774A1 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 07/07/2004 | EP1434772A1 Compounds and methods |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434762A1 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/07/2004 | EP1434761A1 Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434603A2 Method of treatment using ligand-immunogen conjugates |
| 07/07/2004 | EP1434602A2 Cpg formulations and related methods |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434598A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | EP1434584A2 Compositions and methods of treatment of cancer |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1434575A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 07/07/2004 | EP1434567A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 07/07/2004 | EP1401431A4 Human growth hormone antagonists |
| 07/07/2004 | EP1278523B1 Combination of progesterone and mifepristone for cancer therapy |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1087971B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 07/07/2004 | EP1073435B1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 07/07/2004 | EP1047694B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/07/2004 | CN1511161A Novel tricyclic dikydro-quinolin derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/07/2004 | CN1511159A Nitrogen-based camptothecin derivatives |
| 07/07/2004 | CN1511158A Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511154A Quinuclidines-substituted-multi-cycli-heteroaryls for treatment of disease |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511053A HSA-free formulations of interferon-Beta |
| 07/07/2004 | CN1511044A Elogated and multiple spacers in activatible prodrugs |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1511037A Nonintestinal estramustine phosphate and albumin preparations |
| 07/07/2004 | CN1511036A Combination comprising signal transduction inhibitor and epothilone derivative |
| 07/07/2004 | CN1511032A Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 07/07/2004 | CN1510147A Determination of alpha-N-acetamino galactosidase activity |
| 07/07/2004 | CN1510129A Structure for recombinant adenovirus with double killer function and application in tumor treatment |
| 07/07/2004 | CN1510039A Anti-CD 20 embedded antibody mutant gene and its use |
| 07/07/2004 | CN1509764A Preparation of target gene virus medicine against cancers |
| 07/07/2004 | CN1509760A Medicine for preventing and auxiliary treating cancer |
| 07/07/2004 | CN1509758A Chinese medicinal composition for treating lung cancer, preparing method and quality controlling method thereof |
| 07/07/2004 | CN1509742A Medicinal composition for treating cancer |
| 07/07/2004 | CN1509730A Function for pine trunk as medicine for treating tumour |
| 07/07/2004 | CN1156576C Newcastle desease virus HN and chick anemia virus VP3 gene joined antineoplastic biologic preparation |
| 07/07/2004 | CN1156492C Somatostatin peptides |
| 07/07/2004 | CN1156481C Tega fur-containing lecithin compound and its synthesis |
| 07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
| 07/07/2004 | CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/07/2004 | CN1156448C Optical isomer of 3-methyl fentanyl, derivant, synthesizing and its analgesic activity |
| 07/07/2004 | CN1156446C Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 07/07/2004 | CN1156298C Tumor-eliminating ointment and preparation process |
| 07/07/2004 | CN1156274C Medicinal ointment containing zinc conjugated linoleate and sodium humate |
| 07/07/2004 | CN1156269C Liposome composition having resistance to freeze/thaw damage |
| 07/06/2004 | US6760612 Radioactive or magnetic labeled detector molecule which has binding specificity for an epitope of shed tumor antigen administered to patient who is them scanned for localization and concentration of detector |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759522 1-((3,4,5-trihydroxy-6-sulfomethyl-tetrahydropyran-2-yl)-),2 -(fatty acyl),3-(optionally fatty acyl)glycerol; dna polymerase inhibitors; anticancer agents |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759513 Death domain containing receptors |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759417 Vascular endothelial growth factor receptor tyrosine kinase inhibitors; such as 7-amino-6-(1h-benzimidazol-2-yl)-3,4-dihydro-5h-imidazo(4,5-b)pyridin-5-one |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759403 Metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 07/06/2004 | US6759396 Compositions based on a synergistic mixture of at least one VDR ligand and a retinoid |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759211 For cancer use in therapy |
| 07/06/2004 | US6759208 Prevention, therapy disease; forming tritiated water; calibration |
| 07/06/2004 | US6759201 Method of identifying a neural progenitor cell by evaluating expression of daedalos |
| 07/06/2004 | US6759049 Pharmaceutical or dietetic mushroom-based compositions |
| 07/06/2004 | US6759046 Peptides |
| 07/06/2004 | US6759045 Administering antibodies; anticancer agents |
| 07/06/2004 | US6759036 Fibrocyte-base vaccine formulations |
| 07/06/2004 | CA2085201C New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/01/2004 | WO2004055513A2 Use of cd137 antagonists for the treatment of tumors |
| 07/01/2004 | WO2004055210A1 Molecules inhibiting hepatitis c virus protein synthesis and method for screening same |
| 07/01/2004 | WO2004055185A1 Novel protein and dna thereof |
| 07/01/2004 | WO2004055055A1 The transmembrane protein amigo and uses thereof |
| 07/01/2004 | WO2004055053A1 Tumor vaccine |